Discussion of Relationship Between Acute and Chronic Disease Epidemiology by Ostfeld, Adrian M.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 60 (1987), 377
Discussion ofRelationship Between Acute and Chronic
Disease Epidemiology
ADRIAN M. OSTFELD, M.D.
Anna M.R. Lauder Professor ofEpidemiology andPublic Health,
Yale University SchoolofMedicine, New Haven, Connecticut
Received April 9, 1987
Epidemiology and epidemiologists need to be reminded periodically that thedivision
between infectious disease and chronic disease epidemiology is in part arbitrary and
that each field neglects the other at its peril. Kuller's paper in this issue is a valuable
reminder of this arbitrary distinction. Of course there are reasons for this distinction.
Chronic disease epidemiology is so new-only about 35 to 40 years old-that we are
still trying to define what it is and is not. And the sources ofdata are often different in
the two fields. Infectious disease epidemiology gets its data primarily from studies of
infectious agents and measures of immunity in the laboratory; chronic disease
epidemiology, from peices ofpaper filled out in the community and the hospital.
Kuller also makes the interesting and provocative statement that the concept of
multifactorial etiology of many chronic diseases may be a measure of ignorance of
causality rather than a biologic principle.
Let's turn the clock back to 1850 and imagine that we are carrying out a
Framingham type of study of risk factors for pulmonary tuberculosis (TBC). We
would probably find, after some years, that the risk of pulmonary TBC was linearly
and positively related to number of persons living in the same room and inversely
related to occupation, education, nutrition, income, and a measure of adiposity. The
strongest risk factor would be living with or working closely with someone who has a
chronic cough. What good is that information to us? Is it likely to lead to thediscovery
ofthe tubercle bacillus? Probably not, at least in the short run. Can we reduce the risk
ofpulmonary TBC by public health programs based on knowledge ofrisk factors; i.e.,
isolating those with a chronic cough and improving nutrition and housing among those
at high risk? These changes, ifthey were feasible, could reduce the risk ofpulmonary
TBC. Is this where our current knowledge of coronary heart disease lies? Have we
identified multiple risk factors while we are ignorant ofthe agent of transmission and
uncertain about the incubation period? Right now, I don't know, but the problem
deserves careful thought.
Kuller's work has been distinguished by including, wherever possible, clinical and
laboratory markers of the disease in question. This approach-in effect, studying a
chronic disease almost as if it were an infectious disease-has the advantages of
greater precision ofthe disease end-point, more insight into the biology ofthe disease,
and greater opportunity for identifying pathogenic mechanism and, thus, for preven-
tion.
I believe that all those in epidemiology could profit greatly by reviewing Kuller's
paper and pondering its messages.
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